SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001640455-21-000095
Filing Date
2021-05-04
Accepted
2021-05-04 16:26:55
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 jnce05042021s-3.htm S-3 474660
2 EX-4.6 jnce05042021s-3exhibit46.htm EX-4.6 460964
3 EX-4.7 jnce05042021s-3exhibit47.htm EX-4.7 437354
4 EX-4.8 jnce05042021s-3exhibit48.htm EX-4.8 46545
5 EX-4.9 jnce05042021s-3exhibit49.htm EX-4.9 47119
6 EX-5.1 jnce05042021s-3exhibit51.htm EX-5.1 44442
7 EX-23.1 jnce05042021s-3exhibit231.htm EX-23.1 2496
8 wh1.jpg GRAPHIC 18919
9 whfooter1.jpg GRAPHIC 156517
  Complete submission text file 0001640455-21-000095.txt   1756354
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-255760 | Film No.: 21888916
SIC: 2836 Biological Products, (No Diagnostic Substances)